Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria

scientific article published in January 2005

Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1191/0961203305LU2249OA
P698PubMed publication ID16425574

P2093author name stringS Tang
F K Li
K N Lai
T M Chan
C S-O Tang
K C Tse
P2860cites workRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesQ28188162
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyQ29615215
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosusQ33974679
Prognostic factors in lupus nephritis. Contribution of renal histologic dataQ36600287
Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivoQ39741161
Anaemia in dialysis patients as a side-effect of sartanesQ42540628
Add-on angiotensin receptor blockade with maximized ACE inhibitionQ43623110
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideQ43993205
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trialQ44280775
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritisQ44826001
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathyQ45247211
Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.Q46467090
Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy.Q46467093
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathyQ57704237
P433issue12
P921main subjectlupus nephritisQ1621830
P304page(s)947-952
P577publication date2005-01-01
P1433published inLupusQ6704846
P1476titleAngiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria
P478volume14

Reverse relations

cites work (P2860)
Q34044918Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort
Q41540102Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis
Q33882751Current status of lupus nephritis
Q36302245Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
Q43626306New perspectives and insights to Asian systemic lupus erythematosus: renal disease, genetic predisposition and disease activity
Q36915693New treatment strategies for proliferative lupus nephritis: keep children in mind!
Q38123242Overview of lupus nephritis management guidelines and perspective from Asia
Q38175076Overview of lupus nephritis management guidelines and perspective from Asia.
Q37953243Recent advances in the treatment of lupus nephritis
Q33806541Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.
Q38629539Renin-Angiotensin system inhibitors reduce serum asymmetric dimethylarginine levels and oxidative stress in normotensive patients with chronic kidney disease
Q36712941Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Q37113440Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus
Q42728756Treatment of lupus nephritis
Q37822658Treatment of proliferative lupus nephritis: a slowly changing landscape
Q38271125Treatment of severe lupus nephritis: the new horizon.

Search more.